Which Emerging Trends Are Driving The Artificial Pancreas Device System Market Toward $3.46 Billion By 2029?
Claim your 20% discount on Global Market Reports with code ONLINE20. Limited time only.
How Is The Artificial Pancreas Device System Market Expected To Grow In Terms Of Size?
The market size of the artificial pancreas device system has witnessed an accelerated surge in recent times. The sector is predicted to expand from $1.81 billion in 2024 to $2.06 billion in 2025, indicating a compound annual growth rate (CAGR) of 13.8%. Factors contributing to this significant growth during the historic period include increased investment inflows, government-driven clinical research initiatives, heightened demand for automated glycemic control systems, intense R&D pursuits by industry contenders, and a rising elderly demographic.
Expectations are high for the market size of the artificial pancreas device system to experience quick expansion in the nearing years. Projected growth indicates that it will reach $3.46 billion by 2029, showing a compound annual growth rate (CAGR) of 13.8%. The advancing rate during the prediction period can be linked to the escalating incidences of diabetes, growing number of pancreatic cancer cases, increasing rates of diabetes and obesity, heightened demand for minimally invasive (MI) drug delivery systems, and the push for innovation in diabetes management technology. The forecast period is also showing major trends such as technological advancements, escalating research and development initiatives, rise in product approvals, increased partnerships and collaborations, and a surge in tele consultancy activities for patient follow-up.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=18229&type=smp
Which Key Factors Are Fueling Growth In The Artificial Pancreas Device System Market?
The rise in pancreatic cancer incidence is projected to drive the expansion of the artificial pancreas device system market. Pancreatic cancer is a deadly tumor that starts in the pancreas, a gland positioned behind the stomach. It’s influenced by various factors, including lifestyle, genetics, medical conditions, environmental factors, and genetic mutations that trigger hereditary pancreatitis, which can result in chronic pancreas inflammation. The primary function of an artificial pancreas device system (APDS) is to aid those with diabetes in managing their glucose levels by automatically checking glucose and dispensing the necessary amount of insulin. For example, Cancer Australia, a government body, forecasted in March 2024 that 4,506 new instances of pancreatic cancer were identified in 2023, a rise from the 3,751 cases recorded over the previous five years. Hence, the escalating occurrence of pancreatic cancer is fuelling the expansion of the artificial pancreas device system market.
How Is The Artificial Pancreas Device System Market Categorized Across Applications And Types?
The artificial pancreas device systemmarket covered in this report is segmented –
1) By Device Type: Threshold Suspend Device Systems; Control-To-Range Systems; Control-To-Target Systems
2) By Treatment Type: Bi-Hormonal; Insulin Only; Hybrid
3) By End-User: Hospitals; Medical Centers; Other End-Users
Subsegments:
1) By Threshold Suspend Device Systems: Insulin Pump with Threshold Suspend; Continuous Glucose Monitoring (CGM) Integrated Systems
2) By Control-To-Range Systems: Hybrid Closed-Loop Systems; Insulin Delivery Systems with Range Control; Real-Time Glucose Adjustment Systems
3) By Control-To-Target Systems: Fully Closed-Loop Artificial Pancreas Systems; Insulin Pumps with Targeted Glucose Control; Automated Glucose Regulation Systems
Which Emerging Trends Are Reshaping The Artificial Pancreas Device System Market Landscape?
Top organizations involved in the market for artificial pancreas device systems are focused on the advancement of automated insulin delivery mechanisms. These devices are aimed at improving diabetes control by autonomously tracking blood sugar levels and dispensing the necessary insulin amounts. The goal of these systems is to mimic the role of a functioning pancreas, thereby easing the regular task of blood sugar checks and manual insulin injections for individuals dealing with diabetes. For example, in May 2023, Beta Bionics, a medical equipment creation company based in the U.S., obtained FDA 510(k) authorization for their iLet Insulin-Only Bionic Pancreas System. This device, which is an artificial pancreas system, is engineered to independently calculate and dispense insulin doses to regulate blood glucose levels. In this closed-loop system, insulin dosages are auto-adjusted, taking into account the glucose levels recorded by an attached continuous glucose monitor (CGM). The only inputs needed from the user are body weight and an estimate of meal sizes to automatically regulate insulin administration.
Which Firms Are Making The Biggest Impact In The Artificial Pancreas Device System Market?
Major companies operating in the artificial pancreas device system market are Johnson & Johnson, Abbott Laboratories, Medtronic plc, DexCom Inc., Insulet Corporation, Tandem Diabetes Care Inc., Juvenile Diabetes Research Foundation (JDRF), Beta Bionics Inc., Glooko Inc., Bigfoot Biomedical Inc., CeQur SA, Medtrum Technologies Inc., Diabeloop SA, Beta-O2 Technologies Ltd, Pancreum Inc., TypeZero Technologies LLC, Inreda Diabetic B.V., Defymed SAS, Admetsys Corporation, DreaMed Diabetes Ltd
Access The Complete Report Here:
Which Region Holds The Greatest Opportunity For Artificial Pancreas Device System Market Expansion?
North America was the largest region in the artificial pancreas device system market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial pancreas device system market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=18229&type=smp
Browse Through More Reports Similar to the Global Artificial Pancreas Device System Market 2025, By The Business Research Company
Automotive Artificial Intelligence Global Market Report 2025
Artificial Intelligence In Healthcare Global Market Report 2025
Artificial Turf Global Market Report 2025
https://www.thebusinessresearchcompany.com/report/artificial-turf-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
[KClientError] [REQ_ERR: OPERATION_TIMEDOUT] [KTrafficClient] Something is wrong.
